Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Amyloidosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01728259
What this trial is testing

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

Who this might be right for
Light Chain Deposition DiseasePrimary Systemic Amyloidosis
Barbara Ann Karmanos Cancer Institute 18
Not applicableStudy completedNCT02111538
What this trial is testing

Body Composition in Systemic Amyloidosis

Who this might be right for
Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 127
Testing effectiveness (Phase 2)Looking for participantsNCT07266116
What this trial is testing

Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients

Who this might be right for
Systemic Light Chain Amyloidosis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 70
Not applicableStudy completedNCT00536601
What this trial is testing

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+56 more
Roswell Park Cancer Institute 174
Not applicableStudy completedNCT04937777
What this trial is testing

A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe

Who this might be right for
AL Amyloidosis
European Myeloma Network B.V. 4,481
Testing effectiveness (Phase 2)UnknownNCT04316442
What this trial is testing

Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis

Who this might be right for
Light Chain (AL) Amyloidosis
Sorrento Therapeutics, Inc. 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07751471
What this trial is testing

BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004)

Who this might be right for
AL Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT00520767
What this trial is testing

Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease

Who this might be right for
Primary Systemic AmyloidosisLight Chain Deposition Disease
Barbara Ann Karmanos Cancer Institute 35
Early research (Phase 1)Study completedNCT01777243
What this trial is testing

Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis

Who this might be right for
Amyloidosis
GlaxoSmithKline 25
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00006083
What this trial is testing

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

Who this might be right for
Cervical CancerChronic Myeloproliferative DisordersLeukemia+6 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Not applicableUnknownNCT05409833
What this trial is testing

Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population

Who this might be right for
Transthyretin AmyloidosisCarpal Tunnel Syndrome
Universidade do Porto 100
Not applicableLooking for participantsNCT07689331
What this trial is testing

Hungarian National Systemic Amyloidosis Registry

Who this might be right for
Systemic AmyloidosisATTR AmyloidosisAL Amyloidosis+1 more
Semmelweis University 300
Not applicableLooking for participantsNCT06192979
What this trial is testing

Optimize First-line Treatment for AL Amyloidosis With t (11; 14)

Who this might be right for
Amyloidosis; SystemicAL Amyloidosis
Jin Lu, MD 41
Early research (Phase 1)Study completedNCT01406314
What this trial is testing

SAP Depleter Dose Assessment Study in Patients

Who this might be right for
Amyloidosis
GlaxoSmithKline 17
Testing effectiveness (Phase 2)Study completedNCT01194791
What this trial is testing

Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed

Who this might be right for
Primary Systemic Amyloidosis
PETHEMA Foundation 30
Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Next Page